AR111666A1 - Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel - Google Patents

Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel

Info

Publication number
AR111666A1
AR111666A1 ARP180101141A ARP180101141A AR111666A1 AR 111666 A1 AR111666 A1 AR 111666A1 AR P180101141 A ARP180101141 A AR P180101141A AR P180101141 A ARP180101141 A AR P180101141A AR 111666 A1 AR111666 A1 AR 111666A1
Authority
AR
Argentina
Prior art keywords
homeostasis
restore
maintain
topical compositions
skin water
Prior art date
Application number
ARP180101141A
Other languages
English (en)
Original Assignee
Ricerfarma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricerfarma Srl filed Critical Ricerfarma Srl
Publication of AR111666A1 publication Critical patent/AR111666A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Composiciones tópicas que comprenden N,O-carboximetilquitosano y sal de sodio o potasio de octasulfato de sacarosa como ingredientes activos.
ARP180101141A 2017-05-03 2018-05-02 Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel AR111666A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102017000047632A IT201700047632A1 (it) 2017-05-03 2017-05-03 Composizioni topiche per mantenere e ripristinare l'omeostasi idrica della pelle

Publications (1)

Publication Number Publication Date
AR111666A1 true AR111666A1 (es) 2019-08-07

Family

ID=59811930

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101141A AR111666A1 (es) 2017-05-03 2018-05-02 Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel

Country Status (4)

Country Link
AR (1) AR111666A1 (es)
IT (1) IT201700047632A1 (es)
TW (1) TW201842917A (es)
WO (1) WO2018202456A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619995A (en) 1984-12-24 1986-10-28 Nova Chem Limited N,O-carboxymethyl chitosan and preparative method therefor
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
WO1998022114A1 (en) * 1996-11-15 1998-05-28 Dumex-Alpharma A/S A method for promoting tissue repair
EP2737902A1 (en) * 2012-11-28 2014-06-04 Zarzatech, Inc. Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field

Also Published As

Publication number Publication date
WO2018202456A1 (en) 2018-11-08
IT201700047632A1 (it) 2018-11-03
TW201842917A (zh) 2018-12-16

Similar Documents

Publication Publication Date Title
IN2015MU00865A (es)
CL2020001762A1 (es) Formas cristalinas del derivado de 4-pirimidinsulfamida de aprocitentán. (divisional solicitud 201902464)
ECSP16084431A (es) Composiciones estables de yodo no en complejo y métodos de uso
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
CL2015002710A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso.
MA39727A (fr) Compositions antimicrobiennes pour végétaux
PE20171178A1 (es) Composicion de rehidratacion oral y los metodos de la misma
CL2020000220A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CL2011002634A1 (es) Disolucion acuosa sin alcohol etilico que comprende propanolol o una sal farmaceuticamente aceptable del mismo, un edulcorante tipo no azucarado y menos del 0,01 % (p/v) de un agente conservante; procedimiento de preparacion; uso de la disolucion en el tratamiento de hemangiomas.
BR112019005329A2 (pt) composições de oligossacarídeos de leite humano purificadas
BR112017021527A2 (pt) dentifrícios com base em cálcio para acentuar absorção de ingredientes ativos.
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
CL2018002897A1 (es) Sistemas de formulación para glicolípidos antimicrobianos.
AR100456A1 (es) Composiciones dentífricas que tienen estabilidad de ión fluoruro y captación de fluoruro mejoradas
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos
AR100452A1 (es) Composiciones dentífricas que tienen conservantes optimizados
AR112292A1 (es) Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método
CL2020000221A1 (es) Composiciones que comprenden aminoácidos para su uso en el tratamiento de enfermedades relacionadas con la disfunción mitocondrial.
CL2020000551A1 (es) Formulación de uso tópico para el control y la prevención de parásitos en animales.
AR111666A1 (es) Composiciones tópicas que tienen por objeto mantener y restaurar la homeostasis del agua de la piel
TR201909422T4 (tr) Flurbiprofen ve dekspantenolün oral topikal sulu farmasötik bileşimleri.
MX2019003764A (es) Composicion acuosa derivada de agua de mar y de algas marinas.
AR091705A1 (es) Uso de cocet sulfato de zinc como agente antibacteriano contra propionibacterium acnes
AR106659A1 (es) Composiciones dentífricas con experiencia de consumidor mejorada
EA201890911A1 (ru) Комбинация тразодона и габапентина для лечения боли

Legal Events

Date Code Title Description
FB Suspension of granting procedure